Clinical course of severe COVID19 treated with tocilizumab and antivirals post‐allogeneic stem cell transplant with extensive chronic GVHD.
Saved in:
| Title: | Clinical course of severe COVID19 treated with tocilizumab and antivirals post‐allogeneic stem cell transplant with extensive chronic GVHD. |
|---|---|
| Authors: | Mirgh, Sumeet1,2 (AUTHOR), Gokarn, Anant1,2 (AUTHOR), Punatar, Sachin1,2 (AUTHOR), Chichra, Akanksha1,2 (AUTHOR), Singh, Anuj1,2 (AUTHOR), Rajendra, Akhil1,2 (AUTHOR), Babu Goli, Vasu1,2 (AUTHOR), Trivedi, Bhakti2,3 (AUTHOR), Joshi, Amit1,2 (AUTHOR), Patkar, Nikhil2,4 (AUTHOR), Tembhare, Prashant2,4 (AUTHOR), Subramanian, P. G.2,4 (AUTHOR), Shetty, Nitin2,5 (AUTHOR), Chavan, Preeti2,6,7 (AUTHOR), Bhat, Vivek2,7 (AUTHOR), Gupta, Sudeep1,2 (AUTHOR), Khattry, Navin1,2 (AUTHOR) nkhattry@gmail.com |
| Source: | Transplant Infectious Disease. Aug2021, Vol. 23 Issue 4, p1-5. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
